Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

Up, up, up: After Allergan offer, would-be buyer Ackman reaps $1.2B in gains

05.05.2014 / Fierce Pharma

Valeant and partner Bill Ackman may not yet have bagged acquisition target Allergan, but shares have leapt since the takeover team went public with its plans in mid-April, helping push gains for Ackman's hedge fund, Pershing Square Capital Management, to $1.2 billion.

Cover_HCLS_GREECE LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: